BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16437393)

  • 1. Recurrent cerebral gliomas in MRI and Iodine-123[corrected]-alpha-methyl-tyrosine SPECT: the use of digitally fused images.
    Grzelak P; Górska-Chrzastek M; Gajewicz W; Kuśmierek J; Tybor K; Stefańczyk L
    Nucl Med Rev Cent East Eur; 2005; 8(2):94-9. PubMed ID: 16437393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of clinical usefulness of 131I alpha-methyl-tyrosine and fused SPECT/MRI imaging for diagnostics of recurrent cerebral gliomas.
    Górska-Chrzastek M; Grzelak P; Bieńkiewicz M; Tybor K; Zakrzewska E; Mikołajczak R; Stefańczyk L; Kuśmierek J
    Nucl Med Rev Cent East Eur; 2004; 7(2):135-41. PubMed ID: 15968600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between contrast-enhanced magnetic resonance imaging and technetium 99m glucohepatonic acid single photon emission computed tomography with histopathologic correlation in gliomas.
    Kumar RA; Khandelwal N; Sodhi KS; Pathak A; Mittal BR; Radotra BD; Suri S
    J Comput Assist Tomogr; 2006; 30(5):723-33. PubMed ID: 16954918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The usefulness of fused MRI and SPECT images for the voxel positioning in proton magnetic resonance spectroscopy and planning the biopsy of brain tumors: presentation of the method].
    Gajewicz W; Grzelak P; Górska-Chrzastek M; Zawirski M; Kuśmierek J; Stefańczyk L
    Neurol Neurochir Pol; 2006; 40(4):284-90. PubMed ID: 16967349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of recurrent glioma with SPECT and iodine-123-alpha-methyl tyrosine.
    Kuwert T; Woesler B; Morgenroth C; Lerch H; Schäfers M; Palkovic S; Matheja P; Brandau W; Wassmann H; Schober O
    J Nucl Med; 1998 Jan; 39(1):23-7. PubMed ID: 9443732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience.
    Ledezma CJ; Chen W; Sai V; Freitas B; Cloughesy T; Czernin J; Pope W
    Eur J Radiol; 2009 Aug; 71(2):242-8. PubMed ID: 18511228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
    Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal imaging in cerebral gliomas and its neuropathological correlation.
    Gempt J; Soehngen E; Förster S; Ryang YM; Schlegel J; Zimmer C; Meyer B; Ringel F; Grams AE; Förschler A
    Eur J Radiol; 2014 May; 83(5):829-34. PubMed ID: 24629350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolic imaging to follow stereotactic radiation of gliomas -- the role of 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT].
    Lichy MP; Henze M; Plathow C; Bachert P; Kauczor HU; Schlemmer HP
    Rofo; 2004 Aug; 176(8):1114-21. PubMed ID: 15346287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-photon emission computed tomography/computed tomography in brain tumors.
    Schillaci O; Filippi L; Manni C; Santoni R
    Semin Nucl Med; 2007 Jan; 37(1):34-47. PubMed ID: 17161038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of O-(2-18F-fluoroethyl)-L-tyrosine PET and 3-123I-iodo-alpha-methyl-L-tyrosine SPECT in brain tumors.
    Pauleit D; Floeth F; Tellmann L; Hamacher K; Hautzel H; Müller HW; Coenen HH; Langen KJ
    J Nucl Med; 2004 Mar; 45(3):374-81. PubMed ID: 15001676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
    Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
    Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behaviors of cost functions in image registration between 201Tl brain tumor single-photon emission computed tomography and magnetic resonance images.
    Soma T; Takaki A; Teraoka S; Ishikawa Y; Murase K; Koizumi K
    Ann Nucl Med; 2008 Nov; 22(9):825-32. PubMed ID: 19039563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of gadolinium-enhanced MR and thallium-201 single photon emission computed tomography in pediatric brain tumors.
    Rollins NK; Lowry PA; Shapiro KN
    Pediatr Neurosurg; 1995; 22(1):8-14. PubMed ID: 7888393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of IMT-SPECT for postoperative radiotherapy planning in patients with gliomas.
    Grosu AL; Feldmann H; Dick S; Dzewas B; Nieder C; Gumprecht H; Frank A; Schwaiger M; Molls M; Weber WA
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):842-54. PubMed ID: 12377338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive grading of untreated gliomas: a comparative study of MR imaging and 3-(iodine 123)-L-alpha-methyltyrosine SPECT.
    Riemann B; Papke K; Hoess N; Kuwert T; Weckesser M; Matheja P; Wassmann H; Heindel W; Schober O
    Radiology; 2002 Nov; 225(2):567-74. PubMed ID: 12409596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of 123I-IMT SPECT for diagnosis of recurrent non-astrocytic intracranial tumours.
    Plotkin M; Amthauer H; Eisenacher J; Wurm R; Michel R; Wust P; Stockhammer F; Röttgen R; Gutberlet M; Ruf J; Felix R
    Neuroradiology; 2005 Jan; 47(1):18-26. PubMed ID: 15630586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First experience with I-123-alpha-methyl-tyrosine spect in the 3-D radiation treatment planning of brain gliomas.
    Grosu AL; Weber W; Feldmann HJ; Wuttke B; Bartenstein P; Gross MW; Lumenta C; Schwaiger M; Molls M
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):517-26. PubMed ID: 10802381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study.
    Plotkin M; Eisenacher J; Bruhn H; Wurm R; Michel R; Stockhammer F; Feussner A; Dudeck O; Wust P; Felix R; Amthauer H
    J Neurooncol; 2004 Oct; 70(1):49-58. PubMed ID: 15527107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine neoplasm scintigraphy: added value of fusing SPECT/CT images compared with traditional side-by-side analysis.
    Ingui CJ; Shah NP; Oates ME
    Clin Nucl Med; 2006 Nov; 31(11):665-72. PubMed ID: 17053381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.